DK2614090T3 - Hybride cooperative komplekser af hyaluronsyre - Google Patents

Hybride cooperative komplekser af hyaluronsyre

Info

Publication number: DK2614090T3
Authority: DK; Denmark
Prior art keywords: hyaluronic acid; hybrid cooperative; cooperative complexes; complexes; hybrid
Prior art date: 2010-09-09

Application number

DK11769800.1T

Other languages

English (en)

Other versions

DK2614090T4 (da

Inventor

Rosa Mario De

Antonella D'agostino

Gatta Annalisa La

Chiara Schiraldi

Original Assignee

Altergon Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-09-09

Filing date

2011-09-09

Publication date

2017-01-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43528358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2614090(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-09-09 Application filed by Altergon Sa filed Critical Altergon Sa

2017-01-02 Publication of DK2614090T3 publication Critical patent/DK2614090T3/da

2024-07-15 Application granted granted Critical

2024-07-15 Publication of DK2614090T4 publication Critical patent/DK2614090T4/da

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/02—Starch; Degradation products thereof, e.g. dextrin
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/02—Dextran; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Polymers & Plastics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Materials Engineering (AREA)
Dermatology (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)

DK11769800.1T 2010-09-09 2011-09-09 Hybride samvirkende komplekser af hyaluronsyre DK2614090T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ITMI2010A001635A IT1402382B1 (it)	2010-09-09	2010-09-09	Complessi cooperativi ibridi di acido ialuronico
PCT/EP2011/065633 WO2012032151A2 (en)	2010-09-09	2011-09-09	Hybrid cooperative complexes of hyaluronic acid

Publications (2)

Publication Number	Publication Date
DK2614090T3 true DK2614090T3 (da)	2017-01-02
DK2614090T4 DK2614090T4 (da)	2024-07-15

Family

ID=43528358

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK11769800.1T DK2614090T4 (da)	2010-09-09	2011-09-09	Hybride samvirkende komplekser af hyaluronsyre

Country Status (12)

Country	Link
US (2)	US20130165404A1 (da)
EP (1)	EP2614090B2 (da)
CA (1)	CA2810742C (da)
DK (1)	DK2614090T4 (da)
ES (1)	ES2613067T5 (da)
FI (1)	FI2614090T4 (da)
HU (1)	HUE031242T2 (da)
IT (1)	IT1402382B1 (da)
LT (1)	LT2614090T (da)
PL (1)	PL2614090T5 (da)
PT (1)	PT2614090T (da)
WO (1)	WO2012032151A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2596796B1 (en)	2011-11-24	2013-11-13	Quimera Ingenieria Biomedica, S.L.	Complex obtained from hyaluronic acid or a salt thereof and chondroitin sulphate mixtures
ITMI20120896A1 (it)	2012-05-23	2013-11-24	Bongulielmi Reto	Condroitina per uso in medicina
CN104592702B (zh) *	2014-12-26	2017-05-31	四川大学	可自愈合的有机物/无机纳米粒子杂化材料及其制备方法
ITUB20152542A1 (it) *	2015-07-28	2017-01-28	Altergon Sa	Formulati oftalmici a base di complessi cooperativi di acido ialuronico a basso e alto peso molecolare
CN107802597B (zh) *	2017-12-08	2020-07-31	北京诺康达医药科技股份有限公司	一种玻璃酸钠组合物及其制备方法和应用
IT201900006250A1 (it)	2019-04-23	2020-10-23	Fidia Farm Spa	Medicazione per il trattamento della cute lesa
IT201800010415A1 (it) *	2018-11-19	2020-05-19	Innate S R L	Composizione iniettabile comprendente acido ialuronico e trealosio e uso della detta composizione.
IT201900021693A1 (it)	2019-11-20	2021-05-20	Bmg Pharma S P A	Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione
IT201900024214A1 (it)	2019-12-17	2021-06-17	Altergon Sa	Sostituti del liquido sinoviale
IT201900024208A1 (it) *	2019-12-17	2021-06-17	Altergon Sa	Miscele iniettabili di acido ialuronico per uso in dermoestetica
IT202000002866A1 (it)	2020-02-13	2021-08-13	Altergon Sa	Composizioni antivirali
CN113244384A (zh)	2020-02-11	2021-08-13	阿尔特刚股份有限公司	抗病毒组合物
IT202000002641A1 (it)	2020-02-11	2021-08-11	Altergon Sa	Composizioni antivirali
IT202000029288A1 (it)	2020-12-01	2022-06-01	Altergon Sa	Sali di microbiocidi biguanidinici con glicosamminoglicani
CN113512134B (zh) *	2021-07-30	2022-05-20	梅晔生物医药股份有限公司	一种全分子量分布的透明质酸钠及其制备方法和应用
IT202100027047A1 (it)	2021-10-21	2023-04-21	The Wave Innovation Group Srls	Composizione eterogenea a fasi stratificate di acido ialuronico e suo uso intrarticolare
EP4567050A1 (en)	2023-12-04	2025-06-11	Quantum Beauty Cosmetics Joint Stock Company	A method for preparing a cross-linked hyaluronic acid gel

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5166331A (en) *	1983-10-10	1992-11-24	Fidia, S.P.A.	Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US4920104A (en) *	1988-05-16	1990-04-24	Medchem Products, Inc.	Sodium hyaluronate composition
AU652022B2 (en) †	1991-02-12	1994-08-11	C.R. Bard Inc.	Injectable medical device
US5621093A (en) †	1995-06-06	1997-04-15	Anika Research, Inc.	Steam-sterilizing solid hyaluronic acid
US20030104601A1 (en) †	1999-04-01	2003-06-05	Deangelis Paul L.	Chondroitin synthase gene and methods of making and using same
US6482401B1 (en) †	1998-12-23	2002-11-19	Naturopathic Laboratories International, Inc.	Composition for the relief of joint pain and myofascial pain and method of preparing same
EP1165097B1 (en) †	1999-02-01	2007-05-02	Dermal Research Laboratories, Inc.	A pharmaceutical composition of complex carbohydrates and their use
CN1522161A (zh) *	2001-06-29	2004-08-18	�Ȱ�ά��ķ�ɷݹ�˾	批量高压灭菌方法
FR2861734B1 (fr) *	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20070141101A1 (en) *	2003-04-10	2007-06-21	The Trustees Of Boston University	Method for stimulating angiogenesis and wound healing
WO2006043965A1 (en) *	2004-10-14	2006-04-27	Allergan, Inc.	Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
JP2008520392A (ja) †	2004-11-23	2008-06-19	アルコン，インコーポレイティド	天然ポリマーの粘弾性組成物
US20070010481A1 (en)	2005-07-07	2007-01-11	Matrix Biology Institute	Solid State Irradiation of Hyaluronan-Based Solid Preparations, Its Derivatives And Mixtures In An Unsaturated Gaseous Atmosphere And Their Use
CA2621604A1 (en)	2005-09-07	2007-03-15	Amo Regional Holdings	Bi-modal hyaluronate solution
ES2332667T3 (es) *	2006-05-11	2010-02-10	Sandra Gobbo	Mezclas binarias de acido hialuronico y uso terapeutico de las mismas.
ITMI20061030A1 (it) †	2006-05-26	2007-11-27	Altergon Sa	Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
DE102006060953A1 (de) †	2006-12-12	2008-08-07	Farco-Pharma Gmbh	Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
FR2918276B1 (fr) †	2007-07-02	2010-01-22	Anteis Sa	"utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
EA018333B1 (ru) *	2008-05-13	2013-07-30	Афарм С.Р.Л.	Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов
US20100098794A1 (en) *	2008-10-17	2010-04-22	Armand Gerard	Topical anti-wrinkle and anti-aging moisturizing cream
FR2938187B1 (fr) *	2008-11-07	2012-08-17	Anteis Sa	Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
IT1404145B1 (it) †	2010-12-27	2013-11-15	Altergon Sa	Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi

2010
- 2010-09-09 IT ITMI2010A001635A patent/IT1402382B1/it active
2011
- 2011-09-09 PT PT117698001T patent/PT2614090T/pt unknown
- 2011-09-09 LT LTEP11769800.1T patent/LT2614090T/lt unknown
- 2011-09-09 US US13/820,838 patent/US20130165404A1/en not_active Abandoned
- 2011-09-09 ES ES11769800T patent/ES2613067T5/es active Active
- 2011-09-09 PL PL11769800.1T patent/PL2614090T5/pl unknown
- 2011-09-09 HU HUE11769800A patent/HUE031242T2/en unknown
- 2011-09-09 WO PCT/EP2011/065633 patent/WO2012032151A2/en not_active Ceased
- 2011-09-09 FI FIEP11769800.1T patent/FI2614090T4/fi active
- 2011-09-09 DK DK11769800.1T patent/DK2614090T4/da active
- 2011-09-09 CA CA2810742A patent/CA2810742C/en active Active
- 2011-09-09 EP EP11769800.1A patent/EP2614090B2/en active Active
2015
- 2015-12-18 US US14/974,657 patent/US10266611B2/en active Active

Also Published As

Publication number	Publication date
PL2614090T3 (pl)	2017-03-31
IT1402382B1 (it)	2013-09-04
CA2810742C (en)	2018-08-21
EP2614090B1 (en)	2016-11-02
DK2614090T4 (da)	2024-07-15
HUE031242T2 (en)	2017-07-28
PT2614090T (pt)	2017-02-08
ITMI20101635A1 (it)	2012-03-10
WO2012032151A3 (en)	2012-08-30
ES2613067T5 (en)	2025-01-23
EP2614090B2 (en)	2024-04-24
FI2614090T4 (fi)	2024-07-24
CN103119068A (zh)	2013-05-22
EP2614090A2 (en)	2013-07-17
ES2613067T3 (es)	2017-05-22
US10266611B2 (en)	2019-04-23
US20160102154A1 (en)	2016-04-14
PL2614090T5 (pl)	2024-07-29
LT2614090T (lt)	2017-01-25
US20130165404A1 (en)	2013-06-27
WO2012032151A2 (en)	2012-03-15
CA2810742A1 (en)	2012-03-15

Publication	Publication Date	Title
DK2614090T3 (da)	2017-01-02	Hybride cooperative komplekser af hyaluronsyre
EP2714874A4 (en)	2014-11-19	Hybrid nanolubricant
SMT201600370B (it)	2016-11-10	Complessi chelati di oligonucleotidi
EP2684390A4 (en)	2015-02-25	HYBRID OVERLOAD CONTROL
EP2669131A4 (en)	2014-03-26	HYBRID VEHICLE
EP2430278A4 (en)	2015-04-22	HYBRIDBOHRMEISSEL
EP2613954A4 (en)	2015-09-02	HYBRID SYSTEM
EP2543569A4 (en)	2014-07-02	HYBRID LOCOMOTIVE
EP2617595A4 (en)	2016-10-12	HYBRID COMMERCIAL VEHICLE
EP2748644A4 (en)	2015-10-28	HYBRID DETERMINIST GEOSTATISTIC EARTH MODEL
EP2896543A4 (en)	2016-07-27	HYBRID VEHICLE
EP2677961A4 (en)	2014-10-29	HYBRID CATHETER FOR VESSEL HANDLING
EP2779298A4 (en)	2015-09-30	SOLID ELECTROLYTE
EP2646684A4 (en)	2015-02-11	INTEGRATED HYBRID GENERATOR
DE112011103303B8 (de)	2020-01-30	Ladeanschluss
EP2778002A4 (en)	2016-11-30	HYBRID VEHICLE
EP2544262A4 (en)	2014-12-31	BATTERY CONNECTION SYSTEM
BR112012019008A2 (pt)	2015-09-15	soluções estereis de ácido hialurônico
ES2487639T8 (es)	2014-11-03	Híbrido de pigmentos autoaglutinantes
BR112013014592A2 (pt)	2016-09-20	adesivos híbridos estruturais
EP2537726A4 (en)	2013-09-04	HYBRID VEHICLE
EP2922138A4 (en)	2016-07-20	HYBRID BATTERY
CR20140310A (es)	2014-08-20	Agentes de reversión anticoagulante
EP2654170A4 (en)	2016-02-17	CHARGER
EP2786909A4 (en)	2015-12-30	HYBRID VEHICLE